The Effect of Palm Olein, Olive Oil and Lard and on Risk Markers of Cardiovascular Disease (A305)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified August 2008 by University of Copenhagen.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
University of Copenhagen
ClinicalTrials.gov Identifier:
NCT00743301
First received: August 27, 2008
Last updated: NA
Last verified: August 2008
History: No changes posted

August 27, 2008
August 27, 2008
August 2008
February 2009   (final data collection date for primary outcome measure)
total, HDL, LDL cholesterol and triacylglycerol [ Time Frame: before and after each type of dietary fat ] [ Designated as safety issue: No ]
Same as current
No Changes Posted
fasting insulin and glucose, c reactive protein and plasminogen activator inhibitor 1 [ Time Frame: befoer and after each dietary test fat ] [ Designated as safety issue: No ]
Same as current
Not Provided
Not Provided
 
The Effect of Palm Olein, Olive Oil and Lard and on Risk Markers of Cardiovascular Disease
Effects of Palm Olein Versus Olive Oil on Blood Lipids, Lipoproteins and Novel Risk Markers of Cardiovascular Disease

The aim of this study is to compare the effects of a diet rich in palm olein, a fraction of palm oil, to a diet rich in olive oil and a diet rich in Danish lard on plasma total-, LDL and HDL cholesterol as well as triacylglycerol (TAG), fasting insulin and glucose, C reactive protein and plasminogen activator inhibitor 1 in healthy men. The investigators hypothesis is that palm olein and olive oil will have the same effect on plasma total cholesterol, LDL- and HDL concentration and maybe also on the secondary outcome parameters that are related to cardiovascular disease risk. This may be caused by the differences in the sn-positioning of palmitic acid in palm olein. This difference may cause the palmitic acid in palm olein to be more prone to soap formations and excretion than palmitic acid from other sources, e.g. lard.

This study is a double blinded, randomized, controlled 3 x 3 week crossover intervention study, without washout periods. The participants receive the three test foods in random order, decided by draw of lots. Blood samples are drawn in duplicate (on two following days) before and after each dietary period.

Not Provided
Interventional
Not Provided
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Double Blind (Subject, Investigator, Outcomes Assessor)
Primary Purpose: Basic Science
  • Cardiovascular Disease
  • Metabolic Syndrome
Other: Palm olein vs olive oil and lard
17E% from test fat is incorporated into three rolls and a piece of cake
  • Active Comparator: Olive oil
    Intervention: Other: Palm olein vs olive oil and lard
  • Experimental: Palm olein
    Intervention: Other: Palm olein vs olive oil and lard
  • Active Comparator: Lard
    Intervention: Other: Palm olein vs olive oil and lard
Tholstrup T, Hjerpsted J, Raff M. Palm olein increases plasma cholesterol moderately compared with olive oil in healthy individuals. Am J Clin Nutr. 2011 Dec;94(6):1426-32. Epub 2011 Nov 9.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
45
December 2009
February 2009   (final data collection date for primary outcome measure)

Inclusion Criteria:

  1. All participants must give their informed consent in writing, after having received oral and written information about the study
  2. Age: 18-65 y
  3. BMI: 18.5 - 30 mg/m2
  4. Men
  5. Healthy (no known diseases, incl. hypertension, hypercholesterolemia, diabetes and psoriasis)
  6. No use of dietary supplements or blood donations two month prior to and during the intervention

Exclusion Criteria:

  1. Current or previously cardiovascular disease
  2. Diabetes Mellitus or other severe chronic disease, including severe allergies and psoriasis
  3. Hypertension
  4. Known or suspected abuse of alcohol, drugs or medication
  5. Own request: all participants have the right to withdraw from the intervention at any given time without explanation
  6. Compliance: participants may be excluded from the intervention if they do not follow the study guidelines
  7. Side effects (There are no side effects expected in this study since all test fats are commercial available and use in households world wide)
Male
18 Years to 65 Years
Yes
Contact: Marianne Raff, PhD +4535332533 mrf@life.ku.dk
Contact: Tine Tholstrup, PhD +4535332486 tth@life.ku.dk
Denmark
 
NCT00743301
HB2008-056
No
Tine Tholstrup, Dpt Human Nutrition, University of Copenhagen, Denmark
University of Copenhagen
Not Provided
Principal Investigator: Tine Tholstrup, PhD Department of Human Nutrition, University of Copenhagen
University of Copenhagen
August 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP